{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:37:31Z","timestamp":1762954651396,"version":"3.38.0"},"reference-count":57,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Womens Health (Lond Engl)"],"published-print":{"date-parts":[[2007,1]]},"abstract":"<jats:p> Low-molecular-weight heparin is the anticoagulant of choice in pregnancy. Enoxaparin has been increasingly used over the past 20 years in pregnant women at risk of thrombosis and pregnancy complications. The main indications are prophylaxis of venous thromboembolism and prevention of pregnancy loss in thrombophilic women. Other indications include treatment of venous thromboembolism, prophylaxis of arterial thrombosis in pregnant women with mechanical heart valves and prevention of late gestational complication such as pre-eclampsia and intrauterine growth restriction. Enoxaparin does not cross the placenta and is safe for the fetus. Maternal side effects are uncommon and include mild localized allergic reactions in 2% and increased bleeding in 2%, which is dose dependent. Heparin-induced thrombocytopenia is very rare and bone resorption is not clinically relevant. The mechanisms of action of enoxaparin in pregnancy are multiple and include anti-factor Xa (anti-Xa) activity in maternal circulation, tissue factor pathway inhibitor release from endothelial cells and trophoblasts at the placental level as well as anti-inflammatory effects. <\/jats:p>","DOI":"10.2217\/17455057.3.1.9","type":"journal-article","created":{"date-parts":[[2006,12,22]],"date-time":"2006-12-22T23:18:31Z","timestamp":1166829511000},"page":"9-14","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["Enoxaparin Use in Pregnancy: State of the Art"],"prefix":"10.1177","volume":"3","author":[{"given":"Benjamin","family":"Brenner","sequence":"first","affiliation":[{"name":"Caster Chair in Leukemia Research, Bruce Rappaport Faculty of Medicine, Technion, Department of Hematology, Rambam Medical Centre, PO Box 9602, Haifa 31096, Israel, Tel.: +97 248 543 520; Fax: +97 248 542 343;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2007,1,1]]},"reference":[{"unstructured":"Papers of special note have been highlighted as either of interest (\u2022) or of considerable interest (\u2022\u2022) to readers.","key":"bibr0101-17455057.3.1.9"},{"doi-asserted-by":"publisher","key":"bibr1-17455057.3.1.9","DOI":"10.4324\/9780203306994_chapter_13"},{"doi-asserted-by":"publisher","key":"bibr2-17455057.3.1.9","DOI":"10.1055\/s-2003-38829"},{"doi-asserted-by":"publisher","key":"bibr3-17455057.3.1.9","DOI":"10.4324\/9780203306994_chapter_14"},{"doi-asserted-by":"publisher","key":"bibr4-17455057.3.1.9","DOI":"10.1182\/blood-2003-08-2744"},{"doi-asserted-by":"publisher","key":"bibr5-17455057.3.1.9","DOI":"10.1136\/bmj.314.7076.253"},{"doi-asserted-by":"publisher","key":"bibr6-17455057.3.1.9","DOI":"10.1016\/S0735-1097(99)00044-3"},{"doi-asserted-by":"publisher","key":"bibr7-17455057.3.1.9","DOI":"10.1056\/NEJM199111283252213"},{"doi-asserted-by":"publisher","key":"bibr8-17455057.3.1.9","DOI":"10.1016\/S0950-3552(97)80024-7"},{"doi-asserted-by":"publisher","key":"bibr9-17455057.3.1.9","DOI":"10.1378\/chest.108.4_Supplement.258S"},{"doi-asserted-by":"publisher","key":"bibr10-17455057.3.1.9","DOI":"10.1378\/chest.119.1_suppl.122S"},{"doi-asserted-by":"publisher","key":"bibr11-17455057.3.1.9","DOI":"10.1055\/s-2002-34072"},{"unstructured":"Low molecular weight heparin therapy. Sarret M, Kher A, Toulemonde F (Eds). Marcel Dekker Inc., NY, USA, 1\u201325 (1999).","key":"bibr12-17455057.3.1.9"},{"key":"bibr13-17455057.3.1.9","first-page":"479","volume-title":"Bailliere's Clinical Obstetrics and. Gynecology.","author":"Bates SM","year":"1997"},{"doi-asserted-by":"publisher","key":"bibr14-17455057.3.1.9","DOI":"10.1055\/s-0038-1655903"},{"key":"bibr15-17455057.3.1.9","first-page":"243","volume":"30","author":"Dimitrakakis C","year":"2000","journal-title":"Haemost."},{"doi-asserted-by":"publisher","key":"bibr16-17455057.3.1.9","DOI":"10.1111\/j.1439-0264.2005.00642.x"},{"doi-asserted-by":"publisher","key":"bibr17-17455057.3.1.9","DOI":"10.2165\/00003088-200342120-00003"},{"doi-asserted-by":"publisher","key":"bibr18-17455057.3.1.9","DOI":"10.1055\/s-0037-1614550"},{"key":"bibr19-17455057.3.1.9","first-page":"1134","volume":"108","author":"Lepercq J","year":"2001","journal-title":"BJOG"},{"doi-asserted-by":"publisher","key":"bibr20-17455057.3.1.9","DOI":"10.1182\/blood-2005-02-0626"},{"unstructured":"Detailed analysis mainly of safety and also efficacy in approximately 2800 pregnancies treated with low-molecular-weight heparin.","key":"bibr01022-17455057.3.1.9"},{"key":"bibr21-17455057.3.1.9","first-page":"635","volume":"57","author":"Folwarczna J","year":"2005","journal-title":"Pharmacol. Rep."},{"doi-asserted-by":"publisher","key":"bibr22-17455057.3.1.9","DOI":"10.1016\/S0002-9378(99)70091-8"},{"doi-asserted-by":"publisher","key":"bibr23-17455057.3.1.9","DOI":"10.1055\/s-2000-9497"},{"doi-asserted-by":"publisher","key":"bibr24-17455057.3.1.9","DOI":"10.1046\/j.8755-8920.2003.00131.x"},{"doi-asserted-by":"publisher","key":"bibr25-17455057.3.1.9","DOI":"10.1055\/s-0037-1616738"},{"doi-asserted-by":"publisher","key":"bibr26-17455057.3.1.9","DOI":"10.1160\/TH04-06-0345"},{"doi-asserted-by":"publisher","key":"bibr27-17455057.3.1.9","DOI":"10.1097\/01.mbc.0000214710.19116.40"},{"doi-asserted-by":"publisher","key":"bibr28-17455057.3.1.9","DOI":"10.1046\/j.1538-7836.2003.00017.x"},{"doi-asserted-by":"publisher","key":"bibr29-17455057.3.1.9","DOI":"10.1055\/s-2000-9492"},{"doi-asserted-by":"publisher","key":"bibr30-17455057.3.1.9","DOI":"10.1046\/j.1365-2125.2003.01849.x"},{"doi-asserted-by":"publisher","key":"bibr31-17455057.3.1.9","DOI":"10.1111\/j.1365-2141.2004.05304.x"},{"doi-asserted-by":"publisher","key":"bibr32-17455057.3.1.9","DOI":"10.1111\/j.1471-0528.2002.01525.x"},{"doi-asserted-by":"publisher","key":"bibr33-17455057.3.1.9","DOI":"10.1080\/14767050400028626"},{"doi-asserted-by":"publisher","key":"bibr34-17455057.3.1.9","DOI":"10.1001\/archinte.163.6.694"},{"doi-asserted-by":"publisher","key":"bibr35-17455057.3.1.9","DOI":"10.1378\/chest.126.3_suppl.627S"},{"unstructured":"The most recent American College of Chest Physicians guidelines provide balanced information on antithrombotic use in pregnancy.","key":"bibr01038-17455057.3.1.9"},{"doi-asserted-by":"publisher","key":"bibr36-17455057.3.1.9","DOI":"10.1055\/s-0037-1613894"},{"doi-asserted-by":"publisher","key":"bibr37-17455057.3.1.9","DOI":"10.1046\/j.1538-7836.2003.00066.x"},{"doi-asserted-by":"publisher","key":"bibr38-17455057.3.1.9","DOI":"10.1111\/j.1538-7836.2004.01090.x"},{"unstructured":"Multicenter study demonstrating that a 40 mg dose is as effective as an 80 mg dose.","key":"bibr01042-17455057.3.1.9"},{"doi-asserted-by":"publisher","key":"bibr39-17455057.3.1.9","DOI":"10.1016\/j.fertnstert.2005.03.048"},{"unstructured":"Prospective study analyses tissue factor pathway inhibitor (TFPI) and other parameters during treatment of women with thrombophilia.","key":"bibr01044-17455057.3.1.9"},{"doi-asserted-by":"publisher","key":"bibr40-17455057.3.1.9","DOI":"10.1160\/TH05-03-0212"},{"doi-asserted-by":"publisher","key":"bibr41-17455057.3.1.9","DOI":"10.1182\/blood-2003-12-4250"},{"unstructured":"Study demonstrating that enoxaparin 40 mg\/day is more efficient compared with low-dose aspirin in prevention of pregnancy loss in women with thrombophilia.","key":"bibr01047-17455057.3.1.9"},{"doi-asserted-by":"publisher","key":"bibr42-17455057.3.1.9","DOI":"10.1016\/j.fertnstert.2005.12.068"},{"doi-asserted-by":"publisher","key":"bibr43-17455057.3.1.9","DOI":"10.1160\/TH04-01-0033"},{"doi-asserted-by":"publisher","key":"bibr44-17455057.3.1.9","DOI":"10.1111\/j.1538-7836.2005.01564.x"},{"unstructured":"A mechanism for enoxaparin modulation of TFPI at the placental level is suggested.","key":"bibr01051-17455057.3.1.9"},{"doi-asserted-by":"publisher","key":"bibr45-17455057.3.1.9","DOI":"10.1074\/jbc.M207538200"},{"doi-asserted-by":"publisher","key":"bibr46-17455057.3.1.9","DOI":"10.1111\/j.1538-7836.2005.01288.x"},{"doi-asserted-by":"publisher","key":"bibr47-17455057.3.1.9","DOI":"10.1111\/j.1538-7836.2005.01298.x"},{"doi-asserted-by":"publisher","key":"bibr48-17455057.3.1.9","DOI":"10.1016\/j.ajog.2004.03.039"},{"key":"bibr49-17455057.3.1.9","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1055\/s-0037-1619666","volume":"25","author":"Halbmayer WM","year":"2005","journal-title":"Hamostaseologie"},{"doi-asserted-by":"publisher","key":"bibr50-17455057.3.1.9","DOI":"10.1055\/s-0038-1653781"}],"container-title":["Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/17455057.3.1.9","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.2217\/17455057.3.1.9","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/17455057.3.1.9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T14:02:16Z","timestamp":1741615336000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.2217\/17455057.3.1.9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["10.2217\/17455057.3.1.9"],"URL":"https:\/\/doi.org\/10.2217\/17455057.3.1.9","relation":{},"ISSN":["1745-5057","1745-5065"],"issn-type":[{"type":"print","value":"1745-5057"},{"type":"electronic","value":"1745-5065"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}